Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 151 to 160 of 5738 Results
May 22, 2025
Goodyear Announces Sale of Chemical Business
$650 Million
May 21, 2025
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
$330 Million
May 21, 2025
Ceva Animal Health renews its shareholding structure with all its longstanding partners and opens its capital to Mérieux Institute and ARCHIMED to accelerate its growth
Undisclosed
May 20, 2025
Coalesce Capital Acquires Leading Healthcare IT and Business Solutions Provider DAS Health
Undisclosed
May 15, 2025
Lazard advised Stirling Square on the disposal of Axitea, leading provider of digitally enabled surveillance and cybersecurity services, to Argos Wityu
Undisclosed
May 14, 2025
Lazard acted as Sole Financial Advisor to Fitness Park in securing its €280 million unitranche refinancing with Carlyle
$313.6 Million
May 13, 2025
Corsair Capital Announces Close of ~$600 Million Multi-Asset Continuation Vehicle and Secondary Fund
$600 Million
May 13, 2025
TransAlta’s strategic investment in Nova Clean Energy
$175 Million
May 13, 2025
Lazard advised Marstons plc on successfully securing a one-year extension of their £200 million banking facility
$264.2 Million
May 12, 2025